UNSPSC 51281805: Daunorubicin

This classification denotes an anthracycline antibiotic with the molecular formula C27H29NO10, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ZS7284E0ZP, chemically known as 5,12-naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8s-cis)- but generally known as daunorubicin, which bears US NIH Compound Identifier 30323.

UNSPSC 51281805 Daunorubicin is a Commodity code that in recent state and local procurement activity encompasses a broader pharmaceutical and medical supply procurement landscape than the narrow drug name alone suggests. Recent opportunities show state and local governments soliciting pharmaceutical products, medical and first aid supplies, and over-the-counter health products through competitive bidding and cooperative purchasing arrangements. The issuing bodies span state health and human services agencies, county health departments, city fire and rescue divisions, and multistate cooperative purchasing alliances. Work ranges from direct procurement of specific pharmaceutical products and naloxone supplies to manufacturer contracting arrangements and wholesale distribution of generic drugs and medical consumables for public health, emergency response, and employee health programs.

Recent activity clusters in Florida, Texas, Minnesota, and Oregon, with the most substantial volume driven by cooperative purchasing vehicles. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP posted January 20, 2026 with a March 26, 2026 response deadline to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed across state and local government facilities, requiring vendor compliance with cGMP, the Drug Supply Chain Security Act, and relationships with authorized wholesalers including AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co. The Texas Health and Human Services Commission posted a Request for Information April 3, 2026 to solicit vendor capabilities regarding direct-to-manufacturer prescription programs for state pharmacy benefit programs. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries, due July 26, 2026. The City of Tampa's Purchasing Department solicited sealed bids for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division via IFB 26-P-00145, due March 13, 2026, with an estimated contract amount of $700,000 and a 5% bid discount set-aside for certified Small Local Business Enterprises.